Saint Louis University Center for Vaccine Development — St Louis, Missouri

Saint Louis University Center for Vaccine Development is a clinical research site located in St Louis, Missouri, United States 63104-1015.

Crixeo Clinical Trials Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Saint Louis University Center for Vaccine Development has participated in 18 clinical trials with 3 currently active.

Therapeutic areas: COVID-19, Smallpox, Tuberculosis.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), Arizona State University, Daniel Hoft, MD, PhD.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Saint Louis University Center for Vaccine Development?

Saint Louis University Center for Vaccine Development has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Saint Louis University Center for Vaccine Development conducted?

Saint Louis University Center for Vaccine Development has 18 clinical trials on record, with 3 currently active. Their work covers COVID-19, Smallpox, Tuberculosis.

Is Saint Louis University Center for Vaccine Development accredited by Crixeo Clinical Trials?

Saint Louis University Center for Vaccine Development has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Saint Louis University Center for Vaccine Development?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.